Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND)
PaperCitations, authors & open-access status
Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND) is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 97 citations, 2022 year and hybrid oa status.
97
Citations
2022
Year
hybrid
OA Status